Globus Medical (GMED) Misses Q1 EPS by 5c

Go back to Globus Medical (GMED) Misses Q1 EPS by 5c

Globus Medical Reports First Quarter 2022 Results

May 10, 2022 4:15 PM EDT

AUDUBON, Pa., May 10, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2022.

Worldwide net sales were $230.5 million, an increase of 1.4% as compared to the first quarter of 2021GAAP net income for the quarter was $38.1 millionGAAP diluted earnings per share (EPS) was $0.37 and non-GAAP diluted EPS was $0.42Non-GAAP adjusted EBITDA was $74.3 million, or 32.2% of net... More